For laboratory research use onlyNot for human or animal consumption

Lyophilized Peptides

Tirzepatide Research Reference — 100 mg

Catalog material presented by identity, format, availability and applicable lot documentation for qualified laboratory procurement.

CatalogGT-PW-100MG
SourceSee lot documentation
FormatLyophilized Peptides
StatusAvailable
$425.00 Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock

3935 in stock

Current product record, labeling and lot documentation control intended use and handling.

01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context

Lot documentation

Current Certificate of Analysis

13 approved certificates are attached to this product record.

Reported 2026-04-15Lot GT100-042026-499.92% purity · 104.43 mg
Open COA
Reported 2026-04-15Lot GT100-042026-499.92% purity · 104.43 mg
Open COA
Reported 2026-04-15Lot GT100-042026-499.92% purity · 104.43 mg
Open COA
Reported 2026-04-11Lot GT100-042026-199.74% purity · 100.41 mg
Open COA
Reported 2026-04-11Lot GT100-042026-199.74% purity · 100.41 mg
Open COA
Reported 2026-02-07Lot GT1100-1022202599.71% purity · 107.46 mg
Open COA
Reported 2026-02-07Lot GT100-1022202599.707% purity · 107.46 mg
Open COA
Reported 2026-01-31Lot 1006499.747% purity · 94.97 mg
Open COA
Reported 2025-12-17Lot GT16-1213225-J99.811% purity · 11.12 mg
Open COA
Reported 2025-10-27Lot GT100-1022202-J99.4% purity
Open COA
Reported 2025-10-27Lot GT100-1022202-J99.4% purity · 100.55 mg
Open COA
Reported 2025-08-28Lot GT100-08252025-J99.83% purity · 108.4 mg
Open COA
Reported 2025-08-28Lot GT100-08252025-J99.83% purity
Open COA

Technical information

Record at a glance

Primary catalog
Lyophilized Peptides
Product type
Simple product
Availability
Available
Lot control
Current lot documentation and approved product record control
Catalog number
GT-PW-100MG

Intended laboratory context

Illustrative applications

  • Evaluation within the lawful context identified by the current product record
  • Lot-specific documentation review before procurement or laboratory use

Documentation package

Documentation

  • PDFCertificate of Analysis / lot recordSample
  • PDFProduct data or handling recordSample
  • PDFSupporting product media archiveSample
Responsible-use statement

Intended use, handling, storage and limitations are controlled by the current product record, labeling and applicable lot documentation. No dosing or medical guidance is provided.

Need a current record?

Documentation before decision-making.

Reference GT-PW-100MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.

View documentation model